组别 | n | 时间 | CA125 (U/mL) | CEA (μg/L) | CA125阳性 | CEA阳性 |
A组 | 50 | 治疗前 | 43.43 ± 7.80 | 36.12 ± 6.84 | 22 (44.00) | 38(76.00) |
治疗后 | 24.00 ± 2.26 | 12.00 ± 0.36 | 12 (24.00) | 14(28.00) | ||
|
|
| 16.918 | 24.900 | 4.456 | 23.077 |
P组内治疗前后比较 |
|
| <0.001 | <0.001 | 0.035 | <0.001 |
B组 | 50 | 治疗前 | 43.16 ± 7.13 | 37.08 ± 6.37 | 22 (44.00) | 38 (76.00) |
治疗后 | 16.58 ± 2.00 | 2.01 ± 0.30 | 3 (6.00) | 5 (10.00) | ||
|
|
| 25.381 | 38.887 | 19.253 | 44.431 |
P组内治疗前后比较 |
|
| <0.001 | <0.001 | <0.001 | <0.001 |
|
|
| 0.181 | 0.726 | 0.000 | 0.000 |
P组间治疗前比较 |
|
| 0.857 | 0.469 | 1.000 | 1.000 |
|
|
| 17.386 | 150.742 | 6.353 | 5.263 |
P组间治疗后比较 |
|
| <0.001 | <0.001 | 0.012 | 0.022 |